Idiopathic Recurrent Angioedema

Evangelo Frigas, Miguel Park

Research output: Contribution to journalReview article

38 Citations (Scopus)

Abstract

The treatment of idiopathic, chronic, recurrent angioedema with or without urticaria is difficult, both for patients and their physicians, because treatment often is only partially effective and is labor-intensive, expensive, and lengthy. New medications for urticaria and angioedema that currently are being tested clinically may prove effective.

Original languageEnglish (US)
Pages (from-to)739-751
Number of pages13
JournalImmunology and Allergy Clinics of North America
Volume26
Issue number4
DOIs
StatePublished - Nov 1 2006

Fingerprint

Angioedema
Urticaria
Physicians
Therapeutics

ASJC Scopus subject areas

  • Immunology and Allergy

Cite this

Idiopathic Recurrent Angioedema. / Frigas, Evangelo; Park, Miguel.

In: Immunology and Allergy Clinics of North America, Vol. 26, No. 4, 01.11.2006, p. 739-751.

Research output: Contribution to journalReview article

Frigas, Evangelo ; Park, Miguel. / Idiopathic Recurrent Angioedema. In: Immunology and Allergy Clinics of North America. 2006 ; Vol. 26, No. 4. pp. 739-751.
@article{f2c016ba4f064c8eab9da4b2245aefb2,
title = "Idiopathic Recurrent Angioedema",
abstract = "The treatment of idiopathic, chronic, recurrent angioedema with or without urticaria is difficult, both for patients and their physicians, because treatment often is only partially effective and is labor-intensive, expensive, and lengthy. New medications for urticaria and angioedema that currently are being tested clinically may prove effective.",
author = "Evangelo Frigas and Miguel Park",
year = "2006",
month = "11",
day = "1",
doi = "10.1016/j.iac.2006.09.004",
language = "English (US)",
volume = "26",
pages = "739--751",
journal = "Immunology and Allergy Clinics of North America",
issn = "0889-8561",
publisher = "W.B. Saunders Ltd",
number = "4",

}

TY - JOUR

T1 - Idiopathic Recurrent Angioedema

AU - Frigas, Evangelo

AU - Park, Miguel

PY - 2006/11/1

Y1 - 2006/11/1

N2 - The treatment of idiopathic, chronic, recurrent angioedema with or without urticaria is difficult, both for patients and their physicians, because treatment often is only partially effective and is labor-intensive, expensive, and lengthy. New medications for urticaria and angioedema that currently are being tested clinically may prove effective.

AB - The treatment of idiopathic, chronic, recurrent angioedema with or without urticaria is difficult, both for patients and their physicians, because treatment often is only partially effective and is labor-intensive, expensive, and lengthy. New medications for urticaria and angioedema that currently are being tested clinically may prove effective.

UR - http://www.scopus.com/inward/record.url?scp=33750527791&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33750527791&partnerID=8YFLogxK

U2 - 10.1016/j.iac.2006.09.004

DO - 10.1016/j.iac.2006.09.004

M3 - Review article

C2 - 17085288

AN - SCOPUS:33750527791

VL - 26

SP - 739

EP - 751

JO - Immunology and Allergy Clinics of North America

JF - Immunology and Allergy Clinics of North America

SN - 0889-8561

IS - 4

ER -